Glycomics or Glycobiology Market Report 2024: Strategies And Recent Developments | Water Corporation, Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takar

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2367

The Business Research Company offers in-depth market insights through Glycomics or Glycobiology Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.59 billion in 2023 to $1.84 billion in 2024 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification..

The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.38 billion in 2028 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (ai) and data analytics, expansion in glycobiology-based drug development, integration of glycomics in disease biomarker discovery, personalized medicine and glycan-based therapeutics.. Major trends in the forecast period include cross-disciplinary collaborations, glycosylation patterns in disease mechanisms, innovative precision medicine and personalized therapies, advancements in glycoanalytical tools, glycans in immunotherapy and vaccines..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=8749&type=smp

Market Segmentation:
The glycomics or glycobiology market covered in this report is segmented -

1) By Product: Enzymes, Kits, Reagents and Chemicals, Instruments, Carbohydrates
2) By Application: Drug Discovery and Development, Disease Diagnostics, Other Applications
3) By End-user: Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories

Major Driver - Glycomics And Glycobiology Market Driven By Increased Demand For Chronic Disease Medications
The increase in demand for medicines for the treatment of several severe chronic diseases is expected to propel the growth of the glycomics or glycobiology market going forward. Chronic diseases are health problems that are usually long-term and can be controlled but not healed. A glycomics study studies changes in glycosylation and its functions, which helps in the development of drugs and related medications for several severe chronic diseases. For instance, in 2022, according to Cancer Facts and Figures 2022-2024, a scientific paper by the American Cancer Society, there would be 22.5 million cancer (a chronic disease) survivors by 2032, which is projected to reach 26 million by 2040. Thus, the increase in demand for medicines for the treatment of several severe chronic diseases drives the glycomics or glycobiology market.

Competitive Landscape:
Major companies operating in the glycomics or glycobiology market report are Water Corporation, Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., S-BIO Pte. Ltd., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., Sumitomo Bakelite Co. Ltd., Bruker Corporation, AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., IEC Group Ltd., R&D Systems Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

Top Trend - Investments In Research And Development Propel Advances In Glycomics And Glycobiology
Investments in research and development activities are a key trend gaining popularity in the glycomics or glycobiology market. Major research and development institutions are funding research centers for glycobiology, aiming for the research and development of glycomics or glycobiology. For instance, in August 2022, Griffith University, an Australia-based Institute for Glycomics, launched the ACRF International Centre for Cancer Glycomics with a $2.6 million ACRF grant that is dedicated to achieving cancer glycocoding. This is a unique facility, with a better understanding of the glycocode that leads to the translation of novel discoveries and clinical outcomes that would help cancer patients improve their lives.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Glycomics or Glycobiology Market Characteristics
3. Glycomics or Glycobiology Market Trends And Strategies
4. Glycomics or Glycobiology Market - Macro Economic Scenario
5. Glycomics or Glycobiology Market Size And Growth
…..
27. Glycomics or Glycobiology Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.